IL17A, Human (Bimekizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-IL17A, Human (Bimekizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityIL17A, Human (Bimekizumab biosimilar)
CloneBimekizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, FCM, IP, FuncS, IF, Neut
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human IL17A Recombinant Antibody (Bimekizumab). Bimekizumab (INN) is a humanized anti-IL17A and IL-17F monoclonal antibody that is being investigated for ankylosing spondylitis, psoriatic arthritis, and psoriasis. This drug is being developed by Belgian pharmaceutical UCB. As of 2018, bimekizumab is undergoing Phase III trials.
Immunogenn/a
Other NamesAnti-IL17A Recombinant Antibody, Research Grade Bimekizumab, Anti-Human IL17A Recombinant Antibody(Bimekizumab), CDP4940, Antibody Drug Analogues, Monoclonal Antibody, YR1328, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1418205-77-2
Catalog #YR1328
Priceplease inquire
Order / More InfoIL17A, Human (Bimekizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.